Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.
Saved in:
| Title: | Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy. |
|---|---|
| Authors: | Radigan, Rachel1,2 (AUTHOR) rradigan@nyit.edu, Sangal, Ashish3 (AUTHOR), Zhang, Dong2 (AUTHOR), Weber, Jonathan4 (AUTHOR), Schmalzle, Megha1,2 (AUTHOR), Finkelstein, Alexa2 (AUTHOR), Duggal, Vaibhav2 (AUTHOR), Kao, Johnny1,2,3 (AUTHOR) |
| Source: | PLoS ONE. 6/11/2025, Vol. 20 Issue 6, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 185863912 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Radigan%2C+Rachel%22">Radigan, Rachel</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> rradigan@nyit.edu</i><br /><searchLink fieldCode="AR" term="%22Sangal%2C+Ashish%22">Sangal, Ashish</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Dong%22">Zhang, Dong</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weber%2C+Jonathan%22">Weber, Jonathan</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmalzle%2C+Megha%22">Schmalzle, Megha</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Finkelstein%2C+Alexa%22">Finkelstein, Alexa</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Duggal%2C+Vaibhav%22">Duggal, Vaibhav</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kao%2C+Johnny%22">Kao, Johnny</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 6/11/2025, Vol. 20 Issue 6, p1-10. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=185863912 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0325769 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1 Titles: – TitleFull: Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Radigan, Rachel – PersonEntity: Name: NameFull: Sangal, Ashish – PersonEntity: Name: NameFull: Zhang, Dong – PersonEntity: Name: NameFull: Weber, Jonathan – PersonEntity: Name: NameFull: Schmalzle, Megha – PersonEntity: Name: NameFull: Finkelstein, Alexa – PersonEntity: Name: NameFull: Duggal, Vaibhav – PersonEntity: Name: NameFull: Kao, Johnny IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 6/11/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 19326203 Numbering: – Type: volume Value: 20 – Type: issue Value: 6 Titles: – TitleFull: PLoS ONE Type: main |
| ResultId | 1 |
